These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26734955)

  • 21. Is white-coat hypertension a harbinger of increased risk?
    Kollias A; Ntineri A; Stergiou GS
    Hypertens Res; 2014 Sep; 37(9):791-5. PubMed ID: 24599009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular prognosis of sustained and white-coat hypertension in patients with type 2 diabetes mellitus.
    Eguchi K; Hoshide S; Ishikawa J; Ishikawa S; Pickering TG; Gerin W; Ogedegbe G; Schwartz JE; Shimada K; Kario K
    Blood Press Monit; 2008 Feb; 13(1):15-20. PubMed ID: 18199919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study.
    Satoh M; Asayama K; Kikuya M; Inoue R; Metoki H; Hosaka M; Tsubota-Utsugi M; Obara T; Ishiguro A; Murakami K; Matsuda A; Yasui D; Murakami T; Mano N; Imai Y; Ohkubo T
    Hypertension; 2016 Jan; 67(1):48-55. PubMed ID: 26527046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM
    J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White coat hypertension is another clinical characteristic of patients with inflammatory bowel disease: A cross-sectional study.
    Premužić V; Prijić R; Jelaković M; Krznarić Ž; Čuković-Čavka S; Jelaković B
    Medicine (Baltimore); 2022 Nov; 101(44):e29722. PubMed ID: 36343048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients.
    de la Sierra A; Vinyoles E; Banegas JR; Segura J; Gorostidi M; de la Cruz JJ; Ruilope LM
    J Hypertens; 2017 Dec; 35(12):2388-2394. PubMed ID: 28723880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications of White-coat Hypertension Compared to a Normotensive and Hypertensive Population.
    Taher ZA; Khayyat WW; Balubaid MM; Tashkandi MY; Alamoudi SM; Kinsara AJ
    Heart Views; 2021; 22(1):8-12. PubMed ID: 34276882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of white coat hypertension: where are we?
    Nuredini G; Saunders A; Rajkumar C; Okorie M
    Ther Adv Cardiovasc Dis; 2020; 14():1753944720931637. PubMed ID: 32580646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hypertension in suspected hypertensive patients in Rajavithi Hospital using ambulatory blood pressure monitoring.
    Pengkeaw P; Suwannakarn S
    J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S25-30. PubMed ID: 25509692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular Alterations and Management of Patients With White Coat Hypertension: A Meta-Analysis.
    Xiang H; Xue Y; Wang J; Weng Y; Rong F; Peng Y; Ji K
    Front Pharmacol; 2020; 11():570101. PubMed ID: 33041810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. White coat hypertension in children: not rare and not benign?
    Litwin M; Niemirska A; Ruzicka M; Feber J
    J Am Soc Hypertens; 2009; 3(6):416-23. PubMed ID: 20409984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic importance of white coat and masked hypertension].
    Gustavsen P; Hansen TW
    Ugeskr Laeger; 2009 Jun; 171(24):2019-22. PubMed ID: 19523366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study.
    Kushiro T; Kario K; Saito I; Teramukai S; Sato Y; Okuda Y; Shimada K
    Hypertens Res; 2017 Jan; 40(1):87-95. PubMed ID: 27511054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short- and long-term incidence of stroke in white-coat hypertension.
    Verdecchia P; Reboldi GP; Angeli F; Schillaci G; Schwartz JE; Pickering TG; Imai Y; Ohkubo T; Kario K
    Hypertension; 2005 Feb; 45(2):203-8. PubMed ID: 15596572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of white-coat hypertension on arterial stiffness: A meta-analysis.
    Cai P; Peng Y; Wang Y; Wang X
    Medicine (Baltimore); 2018 Oct; 97(42):e12888. PubMed ID: 30335012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between diurnal blood pressure and renal histopathological changes in white coat hypertension.
    Tatar E; Uslu A; Tasli F; Karatas M
    J Nephrol; 2017 Aug; 30(4):551-556. PubMed ID: 28286934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Office blood pressure is a predictor of aortic elastic properties and urinary protein excretion in subjects with white coat hypertension.
    Aznaouridis K; Vlachopoulos C; Masoura K; Pietri P; Vyssoulis G; Ioakeimidis N; Stefanadis C; Tousoulis D
    Int J Cardiol; 2016 Jan; 203():98-103. PubMed ID: 26498870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index.
    Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP
    Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White-Coat Hypertension: the Neglected Subgroup in Hypertension.
    Cuspidi C; Tadic M; Mancia G; Grassi G
    Korean Circ J; 2018 Jul; 48(7):552-564. PubMed ID: 29968429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White coat hypertension and obstructive sleep apnea.
    Li L; Guo LZ; Li J; Wang Y; Liu X; Lv YH; Ma CS
    Sleep Breath; 2015 Dec; 19(4):1199-203. PubMed ID: 25680548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.